Medvi vs Clinic Secret

Choose Clinic Secret if: You want medication flexibility through both semaglutide AND tirzepatide formulary allowing GLP-1 selection based on efficacy preference or tolerability, willing to pay $600-1,800/year premium ($2,964-4,764/year vs Medvi $2,388-2,988/year) for dual-medication options, prefer tirzepatide superior efficacy (20.2% versus 13.7% average body weight loss in the SURMOUNT-5 head-to-head trial of the brand-name drugs; individual results vary), need medication alternatives if intolerant to semaglutide, value treatment optimization options through multiple GLP-1 choices, or prioritize medication flexibility over absolute minimum pricing.

Choose Medvi if: You prioritize absolute lowest GLP-1 pricing ($2,388-2,988/year) saving $600-1,800 annually vs Clinic Secret, satisfied with semaglutide-only formulary without tirzepatide access, accept medication limitation for cost savings (20-38% cheaper), don't require treatment alternatives or medication optimization flexibility, extreme cost sensitivity drives decision-making over clinical options, or make purchasing decisions based primarily on minimum price regardless of formulary restrictions.

Bottom line: Clinic Secret and Medvi represent ultra-budget tier of GLP-1 telehealth with minimal service differentiation beyond pricing and formulary breadth. Medvi operates as lowest-cost provider ($199-249/month, $2,388-2,988/year) through a semaglutide-only formulary and minimal overhead, delivering 20-38% savings vs Clinic Secret. Clinic Secret positions slightly upmarket ($247-397/month, $2,964-4,764/year) offering both semaglutide AND tirzepatide providing medication flexibility and treatment optimization options justifying $600-1,800 annual premium. Both platforms provide medication-only models without lifestyle programming, full medical support, or established track records. Choice depends on whether medication formulary breadth (Clinic Secret dual-GLP-1 options) justifies $600-1,800/year premium or absolute minimum pricing (Medvi ultra-budget) prioritized accepting semaglutide-only limitation. For patients specifically wanting tirzepatide superior efficacy or medication alternatives, Clinic Secret required regardless of cost premium. For extreme cost sensitivity satisfied with semaglutide, Medvi delivers meaningful savings. Neither platform offers compelling non-price advantages - established platforms (Henry Meds, hims, Eden) provide superior maturity, medical support, and service quality at modestly higher costs. Budget tier competition reduces to formulary breadth vs minimum pricing trade-off.